Apollo Ebitda from 2010 to 2024

APOLLOHOSP   7,258  64.45  0.90%   
Apollo Hospitals' EBITDA is increasing with slightly volatile movements from year to year. EBITDA is estimated to finish at about 25.2 B this year. For the period between 2010 and 2024, Apollo Hospitals, EBITDA quarterly trend regression had mean deviation of  6,613,225,545 and range of 24.4 B. View All Fundamentals
 
EBITDA  
First Reported
2018-06-30
Previous Quarter
7.1 B
Current Value
8.6 B
Quarterly Volatility
1.8 B
 
Covid
Check Apollo Hospitals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apollo Hospitals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.2 B, Interest Expense of 4.7 B or Selling General Administrative of 1.4 B, as well as many indicators such as . Apollo financial statements analysis is a perfect complement when working with Apollo Hospitals Valuation or Volatility modules.
  
This module can also supplement various Apollo Hospitals Technical models . Check out the analysis of Apollo Hospitals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Apollo Stock

Apollo Hospitals financial ratios help investors to determine whether Apollo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apollo with respect to the benefits of owning Apollo Hospitals security.